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Abstract
Background: The cellular prion protein (PrP
C) plays a key role in the pathogenesis of Transmissible Spongiform
Encephalopathies in which the protein undergoes post-translational conversion to the infectious form (PrP
Sc). Although
endocytosis appears to be required for this conversion, the mechanism of PrP
C internalization is still debated, as caveolae/
raft- and clathrin-dependent processes have all been reported to be involved.
Methodology/Principal Findings: We have investigated the mechanism of PrP
C endocytosis in Fischer Rat Thyroid (FRT)
cells, which lack caveolin-1 (cav-1) and caveolae, and in FRT/cav-1 cells which form functional caveolae. We show that PrP
C
internalization requires activated Cdc-42 and is sensitive to cholesterol depletion but not to cav-1 expression suggesting a
role for rafts but not for caveolae in PrP
C endocytosis. PrP
C internalization is also affected by knock down of clathrin and by
the expression of dominant negative Eps15 and Dynamin 2 mutants, indicating the involvement of a clathrin-dependent
pathway. Notably, PrP
C co-immunoprecipitates with clathrin and remains associated with detergent-insoluble
microdomains during internalization thus indicating that PrP
C can enter the cell via multiple pathways and that rafts
and clathrin cooperate in its internalization.
Conclusions/Significance: These findings are of particular interest if we consider that the internalization route/s undertaken
by PrP
C can be crucial for the ability of different prion strains to infect and to replicate in different cell lines.
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Introduction
Prion diseases are fatal neurodegenerative disorders which are
often characterized by a cerebral accumulation of a protease-
resistant, misfolded isoform of the prion protein, PrP
Sc (scrapie
PrP), which derives from the glycosylphosphadidyl inositol (GPI)-
anchored cellular isoform PrP
C (cellular PrP) [1–3]. Compared to
PrP
C, PrP
Sc contains an increased number of b-sheet structures, is
partially proteinase K-resistant and aggregates and accumulates in
the brain [4]. The mechanisms involved in PrP
C to PrP
Sc
conversion are unknown and controversy exists regarding the
precise subcellular localization of this event. Both PrP
C and PrP
Sc
have been localized to the plasma membrane and have been
shown to undergo endocytosis [5,6] and this appears to be
required both for prion infection and conversion [7–12].
Internalization of molecules can occur through the classical,
clathrin-mediated pathway for which many molecular components
are known [13] and/or via non-classical clathrin-independent
routes [14–16]. Numerous clathrin-independent pathways are
emerging [17]; among these the raft-dependent route can be
subdivided into caveolae-dependent and caveolae-independent
pathways [18]. Caveolae are membrane invaginations considered
to be specialized raft domains, which originate from the
oligomerization of their integral coat proteins, the caveolins
[19,20]. They are involved in the uptake of cholera toxin (CTxB),
viruses [21–23], as well as in the internalization of cross-linked
GPI-anchored proteins (GPI-APs)[21,24] and transmembrane
receptors like TGFb and EGFR [25,26]. CTxB, tetanus toxin
and non cross-linked GPI-anchored proteins are also internalized
by less well defined mechanisms involving membrane micro-
domains known as ‘‘lipid rafts’’, ‘‘detergent resistant microdomains
(DRMs) or ‘‘caveolae-like domains’’ (CLDs), which have similar
lipid composition to caveolae but lack cav-1 [27–29]. However,
clathrin-dependent and -independent pathways of internalization
may not be as distinct as previously thought [30,31]. Indeed, lipid
rafts have also been implicated in the control of clathrin-mediated
internalization of some receptors, such as the BCR (B cell
receptor). Interestingly, this receptor can also be internalized by
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5829these microdomains independently of clathrin. The observation
that the BCR can be endocytosed by both clathrin- and raft-
dependent mechanisms may appear paradoxical if one considers
that prototypical clathrin-coated pits internalized receptors are not
enriched in lipid rafts [32,33]. Nonetheless, recent reports suggest
a connection between mechanisms regulating cell signalling and
endocytosis [30,34,35]. Indeed, Puri and colleagues have demon-
strated that the EGFR-internalizing clathrin-coated pits can
assemble within lipid rafts which could represent the cellular sites
to coordinate EGFR signalling and internalization [34]. Specifi-
cally, lipid rafts might act as platforms that spatially link the
signalling machinery with clathrin to regulate the internalization
process of specific molecules.
One class of molecules that seem to have access to many of these
different pathways are the GPI-anchored proteins (GPI-APs). Non
cross-linked GPI-APs are constitutively internalized through a
pathway that is independent of clathrin and Dynamin (Dyn) and
dependent on rafts and Cdc-42 [29]. However when they are
cross-linked they are internalized via caveolae [24,36,37] but they
can also enter the clathrin-dependent pathway when interacting
with transmembrane proteins possessing a clathrin-coated pit
internalization signal [37].
Consistent with these findings, the GPI-AP PrP
C has been
shown to be internalized by either clathrin-dependent [38–41], or
raft-mediated pathways [42], depending upon the cell types and
the different techniques utilized. Furthermore, although there is no
direct evidence for caveolae-dependent internalization, the
presence of PrP
C in caveolae-like domains [8,9] and its
colocalization with cav-1 [12,43] suggested an involvement of
caveolae in PrP
C endocytosis.
Understanding the endocytic itinerary of PrP
C is fundamental,
since data in the literature indicate that both general inhibition of
endocytosis [8,12] and/or a direct modification of the internal-
ization route of PrP
C, by replacing the GPI anchor with a
transmembrane sequence containing a coated pits localization
motif [9], affect both the infection and the conversion processes
[3,44].
Using a combined approach of immunofluorescence, electron
microscopy and biochemistry we have followed and characterized
the internalization of mouse PrP (moPrP) transfected in FRT
(Fischer Rat Thyroid) cells that do not express cav-1 and do not
have caveolae (FRT-PrP
C), as well as in FRT cav-1 cells (FRT-
PrP
C/cav-1) which form caveolae [45].
We report that PrP
C internalization is delayed by interfering
with either the clathrin-dependent or the raft-mediated pathway
but is not affected by caveolin expression. We also found that PrP
C
is in DRMs during the internalization period and co-immunopre-
cipitates with clathrin from DRMs fractions. Overall our data
indicate that lipid rafts and clathrin cooperate for PrP
C
internalization. Consistent with this, PrP
C internalization is
completely blocked only under simultaneous impairment of both
clathrin and lipid rafts.
Results
Endocytosis of PrP
C is dependent on cholesterol but
independent of cav-1
Although PrP
C has been previously reported to be in caveolae
[43] or caveolae-like domains [8,9], there is no direct experimental
evidence demonstrating or disproving a role for caveolae in PrP
C
internalization.
FRT cells stably transfected with mouse PrP (moPrP) cDNA
(FRT-PrP
C cells) have previously been used to characterize the
exocytic pathway of PrP
C and PrP
C mutants [46–48]. Further-
more, these cells represent an ideal system to test whether caveolin
and caveolae are involved in PrP internalization because they do
not express cav-1 and caveolae but form functional caveolae
following transfection of cav-1 [45]. Therefore, to directly assess
the possible role for caveolae in PrP
C internalization, we stably
transfected FRT-PrP
C cells with a cDNA encoding for human cav-
1. Consistent with previous reports [45], transfection of cav-1 was
sufficient to promote de novo formation of caveolae in FRT-PrP
C
cells and at steady-state cav-1 was found to be associated with
smooth flask-shaped invaginations at the plasma membrane
(Figure S1A a, 15 nm gold). Interestingly, double-immunolocali-
zation on ultrathin cryosections with aPrP and acav-1 antibodies
(respectively 10 and 15 nm gold), revealed colocalization of the
two proteins on caveolae stemming from the cell surface (a). In
order to characterize the endocytic pathway followed by PrP
C,w e
developed an indirect immunofluorescence assay in cells grown in
polarized conditions, which allowed us to distinguish between
internalized and surface protein (Figure 1A, Materials and
Methods). By confocal microscopy, we observed that PrP
C begins
to enter the cells after 15 minutes of incubation at 37uC, and shows
a peak of internalization after 30 min (Figure 1A, FRT-PrP
C).
This slow kinetic of endocytosis is compatible with a caveolae or
caveolae-like mediated internalization pathway [49]; however in
FRT-PrP
C/cav-1 cells PrP
C was internalized with similar kinetics
to wild type cells (compare the panels of Figure 1A FRT-PrP
C and
FRT-PrP
C/cav-1), showing a peak of internalization at 30 min.
Therefore, these data show that cav-1 and caveolae did not affect
PrP
C endocytic trafficking. Noteworthy, in line with the EM data,
immunofluorescence analysis revealed that although at steady-
state PrP
C and cav-1 are both preferentially localized at the cell
surface (Figure S1C), once internalized they were never found to
share the same intracellular distribution neither after 30 min nor
after 60 min (the same is for 15 min, not shown) (Figure S1D).
Interestingly, morphometric analysis of EM data (Figure S1A
and see below) indicated that PrP
C is found in clathrin-coated pits
in both FRT-PrP
C and FRT-PrP
C/cav-1 cells in similar amounts
indicating that transfection of cav-1 does not alter the plasma
membrane distribution of PrP
C.
Altogether these data indicate that cav-1 transfection did not
affect the internalization levels or kinetics of PrP
C that we had
observed in the absence of caveolae demonstrating that although
PrP
C can be found in caveolae it is not endocytosed via those
structures.
Having excluded a role for caveolae we next analyzed the role
of rafts which have been implicated in the uptake of different GPI-
anchored proteins and of PrP
C itself [12,42]. Because raft-
mediated internalization is sensitive to drugs that interfere with
the homeostasis of cholesterol in membranes, we depleted cells of
cholesterol by mevinolin/methyl-b-cyclodextrin using conditions
that lowered cholesterol to ,50% of normal levels and that have
been shown to impair PrP
C raft association [46,50,51], (Materials
and Methods). Interestingly, under these conditions the kinetics of
PrP
C endocytosis was decreased and a peak of internalization
occurred only after 60 min of chase both in FRT-PrP
C and FRT-
PrP
C/cav-1 cells (Figure 1B).
In order to quantify these data and to avoid the use of full IgG
molecules, which have been previously shown to cross-link GPI-
anchored proteins and eventually change their internalization
pathway [36,40,52], we used a biochemical internalization assay
based on the use of a reducible biotin reagent [53] (Figure 1C, D).
FRT and FRT-cav1 cells expressing PrP
C were grown on filters
and then selectively biotinylated on the basolateral surface with
NHS-LC-SS-Biotin and chased at 37uC for the indicated times to
allow internalization. By addition of glutathione, which reduces
Endocytosis of PrP
C
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C internalization is delayed by cholesterol depletion but it is not affected by caveolin expression. A) and
B) FRT-PrP
C cells or FRT-PrP
C/cav-1 grown on transwell filters were subjected to indirect immunofluorescence under control (A) and cholesterol
depletion conditions (B). Cells were incubated for 30 min with aPrP antibody (SAF32) at 4uC on the basolateral side of the filters and subsequently,
warmed up to 37uC to allow PrP
C internalization for the indicated times. Surface PrP
C is labelled in green, while internalized PrP
C is in red (see
Materials and Methods for experimental procedure). Bar: 10 mm. FRT-PrP
C (C) or FRT-PrP
C/cav-1 cells (D), grown under control and cholesterol
depletion conditions on transwell filters, were subjected to a biotinylation based endocytic assay (see Materials and Methods). PrP
C was
immunoprecipitated with SAF32 antibody and the surface and the internalized PrP
C were revealed by western blotting with streptavidin-HRP. E) and
F) The data from four independent experiments performed in C) and D) respectively were quantified using NIH-image for MacIntosh, and plotted in
the graphs. The amount of biotinylated internalized PrP
C was expressed as a percentage of the amount of PrP
C on the surface at 4uC, which we set as
100%. Error bars are indicated. Note that the different smear corresponding to PrP
C between Figure 1C and 1D is due to differences in the gel
migration and not to differences in PrP
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internalized proteins, we could discriminate between the cell
surface and the internalized PrP
C fractions, at the different chase
times. Interestingly, the amount of internalized PrP
C was not
changed by lowering cholesterol levels. Indeed, about 20% of
surface PrP
C was internalized in both control and cholesterol
depleted cells (Figure 1C, D and E, F). However, in agreement
with the immunofluorescence data, the biotinylation assay showed
that the kinetics of PrP
C internalization was delayed by cholesterol
depletion resulting in a peak of internalization at 60 minutes in
contrast to 30 minutes for control cells (Figure 1C, D and E, F).
These results (Figure 1 and S1A, D) further exclude a role for
caveolae in PrP
C uptake and support the involvement of a
cholesterol-dependent mechanism suggesting a role for lipid rafts
in this process.
Importantly, in order to exclude pleiotropic effects of cholesterol
depletion on membrane function, including inhibition of clathrin-
dependent internalization, previously reported in other cell lines
by acute cholesterol depletion [54,55], we could show that
cholesterol depletion did not impair internalization of Transferrin
(Tfr), a marker of the clathrin-dependent endocytosis (Figure S2A,
B and Supporting information for fluorescence quantification).
Internalization of PrP
C depends on Cdc-42 activity, Dyn 2
and Eps15-AP2 binding
The results presented above, that PrP
C endocytosis was slowed
down but not completely blocked by cholesterol depletion, could
be explained by two possibilities. Either the molecular mechanism
involved in the PrP
C endocytic pathway is not solely dependent on
membrane rafts, or under partial cholesterol depletion conditions
the raft-dependent endocytic pathway still functions, albeit less
efficiently.
Since PrP
C has been shown to be internalized both via a raft-
dependent or a clathrin-dependent pathway [38–40,56] depend-
ing on the cell lines and the experimental methods utilized, we
decided to dissect the endocytic pathway of PrP
C by identifying the
specific molecular factors involved in its uptake. To this aim we
tested whether the transient expression of dominant-negative
mutants of known molecules involved in different endocytic
pathways would perturb PrP
C internalization. Specifically, we
expressed the GFP-tagged versions of the dominant-negative
isoform of Cdc-42, Dyn 2 and Eps15 and employed a fluorescent
microscopy-based internalization assay to follow PrP
C (Figure 2).
As positive and negative controls we used fluorescently labelled Tfr
or CTxB as markers of the clathrin- or raft-dependent routes
respectively (Figure S3).
First, we analyzed the effect of the dominant-negative, GFP-
tagged Cdc-42 isoform (Cdc-42 N17). Cdc-42 is a component of
the Rho family of GTPases and has been shown to be specifically
involved in the clathrin-independent endocytosis of GPI-anchored
proteins [29] the FGF2 receptor [57] and the Helicobacter pylori
VacA cytotoxin [58]. By quantification of the fluorescence (see
Material and Methods) we found that the expression of Cdc-42
N17, but not the wild-type GFP-linked form, reduces the amount
of internalized PrP
C per cell (Figure 2 and Table 1). As expected,
Cdc-42 N17 had only a slight effect on the internalization of Tfr
(Table 1, and Figure S4) thus indicating that in FRT cells PrP
C
might be internalized via a raft-mediated pathway dependent
upon activation of Cdc-42.
To further characterize this pathway we analyzed the effect of
Rho-GDI expression on PrP
C and Tfr internalization in these
cells. Rho-GDI overexpression locks Cdc-42 in a GDP-inactive
state resulting in its removal from the membrane-associated pool.
As expected from the results on the effect of mutant Cdc-42, the
internalization of PrP
C was also perturbed in FRT cells transfected
with a His6-tagged form of Rho-GDI (Figure 2 and Table 1).
However, we did not find any effect of the Rho-GDI on Tfr
internalization (Figure S3 and Table 1). This is in agreement with
data showing that clathrin-mediated endocytosis is mainly
regulated by Rho and Rac which, opposite to Cdc-42, need to
be locked in the active state to block internalization [59]. Because
raft-mediated internalization can be either Dynamin-dependent or
-independent [60,61], we decided to examine the involvement of
Dyn 2 by using the Dyn 2 K44A dominant-negative mutant,
which has been extensively used as a tool to block the fission of
endocytic intermediates [62–64]. Consistent with previous reports,
transient transfection of a GFP-tagged Dyn 2 K44A cDNA
impaired the clathrin-dependent internalization of Tfr [65] (Figure
S3 and Table 1). Similarly, PrP
C endocytosis was also perturbed
under these conditions. In contrast, in control cells expressing
wild-type Dyn 2, both PrP
C and Tfr were internalized normally
(Figure 2, Table 1 and Figure S3). This result could be explained
either by an involvement of a raft-mediated Dyn 2–dependent
internalization of PrP
C or by the involvement of a clathrin-
mediated pathway in PrP
C endocytosis. In order to test this latter
hypothesis we used the isoform of Eps15 mutated in the AP2
binding domain (Eps15 D95/295), that has been demonstrated to
selectively inhibit clathrin-mediated endocytosis [26,66], and
followed both PrP
C and Tfr internalization. We found that the
transient transfection of the dominant-negative mutant but not of
the wild-type Eps15 decreased the endocytosis of both PrP
C and
Tfr (Figure 2, Table 1 and Figure S3), thus supporting the
involvement of clathrin in PrP
C internalization. As an alternative
approach we transiently transfected in FRT cells a siRNA directed
against the clathrin heavy chain (CHCsiRNA)[67] which resulted
in an efficient reduction of detectable clathrin as well as reduced
internalization of PrP
C and Tfr in transfected cells (Figure 3A and
Table 1). Collectively, the results obtained using both siRNA and
dominant-negative mutants show that PrP
C internalization is
cholesterol-dependent and is regulated by molecular factors
involved in both raft- and clathrin-dependent pathways.
PrP
C internalization is blocked only by the combined use
of hypertonic medium and cholesterol depleting drugs
The data presented above support roles for both clathrin- and a
raft- mediated pathways in PrP
C internalization. In order to
quantitatively define their respective involvement we performed
the biotinylation-based endocytic assay described above utilizing a
hypertonic milieu that causes the disruption of clathrin lattices
[68], in combination or not with cholesterol depletion (Figure 3B).
Intriguingly, disruption of clathrin lattices affected PrP
C internal-
ization in a manner similar to cholesterol depletion. Specifically,
both treatments delayed the kinetics of endocytosis by 30 minutes
without altering the total amount of the internalized protein
(Figure 3B). These results suggest that both clathrin- and raft-
dependent pathways are utilized for PrP
C internalization;
therefore, a testable prediction of this hypothesis is that it should
be possible to completely block PrP
C uptake by pharmacologically
poisoning both pathways simultaneously. To this end we measured
PrP
C internalization in cells subjected to a combined treatment of
cholesterol depletion and exposure to a hypertonic milieu.
Consistent with the stated hypothesis, under these conditions
PrP
C uptake was completely blocked (Figure 3B) suggesting that
clathrin-dependent and cholesterol/raft-dependent pathways ac-
count for all the routes of PrP
C internalization. Importantly, under
these conditions both the staining of a basolateral protein marker
Antigen 35/40 kDa as well as the values of the transepithelial
resistance (TER) of the monolayers were unaffected (Figure S5),
Endocytosis of PrP
C
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the plasma membrane. The hypothesis of the involvement of both
clathrin- and raft- dependent pathways in the endocytosis of PrP
C,
was also strengthened by the analysis of its distribution at steady-
state and during internalization by Electron Microscopy (Figure 4).
Immunogold labeling on ultrathin cryosections of FRT-PrP
C cells
at steady-state shows that PrP
C (15 nm) localizes mainly in smooth
areas and invaginations of the plasma membrane (Figure 4a, b) but
also in morphologically identified clathrin-coated pits and vesicles
(Figure 4c) and after 30 min at 37uC in the endolysosomal
compartment (d, e).
Clathrin and lipid rafts cooperate for PrP
C internalization
The utilization by PrP
C of both routes of internalization raises
the question as to how these two pathways are regulated and how
they control PrP
C endocytosis. Whether they are completely
separate or overlapping, or whether they interact. Indeed, there
are three possible models to explain our previous data: either PrP
C
moves laterally out of lipid rafts before undergoing endocytosis by
‘‘classical’’ clathrin-dependent pathway as previously proposed
[40], or clathrin directly associates with PrP
C-containing rafts as
shown in the case of the BCR [30] and CTxB [35] or PrP
C is
internalized by both the clathrin- and raft-mediated pathways as
independent spatially segregated mechanisms.
To discriminate among these three mechanisms, we analyzed
the association between PrP
C and DRMs both on the cell surface
and during internalization (Figure 5A). After treatment with
disulfide-linked biotin, cells were incubated at 37uC to allow
endocytosis and were subjected to density gradient purification in
order to discern PrP
C raft-association. We found that PrP
C was
present in DRMs and that it remained associated with them
during the entire internalization time, suggesting that it does not
exit ‘‘raft domains’’ to be internalized via the clathrin-coated pits.
This result suggested that PrP
C internalization via clathrin
pathway was occurring in raft domains. Notably, we obtained
the same results in the neuronal cell model of GT-1 [69] where
PrP
C associates with DRMs both on the surface and after
internalization (Figure 5B). Interestingly, this is in contrast with
observations in N2a cells where it is reported that the internalized
pool of PrP
C is not associated to DRMs [40]. Interestingly, we
could confirm these results using our experimental conditions in
N2a cells, showing that internalized PrP
C exits from DRMs
(Figure 5B). These data support the hypothesis that PrP
C can enter
different cell lines using different internalization routes [42]. Since
internalized PrP
C remains associated with rafts both in FRT and
GT-1 cells, we assessed whether PrP
C was associated with rafts and
clathrin simultaneously.
To test this hypothesis we performed co-immunoprecipitation
assays between PrP
C and the heavy chain of clathrin (CHC) and
found that the two proteins co-immunoprecipitate (Figure 6A). As
negative control of the procedure we used p75
NTR [the
neurotrophin receptor known to be internalized via a clathrin-
independent pathway in neurons [70]], that indeed does not
coimmunoprecipitate with clathrin.
Then, in order to understand whether PrP
C and clathrin co-
immunoprecipitate inside or outside DRMs, we first analyzed the
distribution of the two proteins on a OptiPrep
TM density gradient
(Figure 6B, top panel) and then performed co-immunoprecipita-
tion assays from the DRM and non-DRM fractions of the
gradients. As expected PrP
C and clathrin showed an opposite
enrichment, respectively in DRM and non-DRM fractions of the
gradients (Figure 6B, top panel).
However, we found that clathrin co-immunoprecipitated with
PrP
C both from the DRM and non-DRM fractions (Figure 6B,
lower panel). Because we have shown that all internalized PrP
C is
in DRMs (Figure 5A), the portion of PrP
C that co-immunopre-
Figure 2. PrP
C internalization is impaired by transfection of Cdc-42, Dyn 2, Eps15 GFP-tagged dominant-negative mutants and of
Rho-GDI (His6-tagged form). FRT-PrP
C cells were transiently trasfected with the His6-tagged form of Rho-GDI or with the wild-type (wt) or
dominant negative mutant isoforms of GFP-tagged Eps15 (Eps D95/295), Cdc-42 (Cdc-42 N17) or Dynamin 2 (Dyn 2 K44A). Cells were then challenged
with SAF32 antibody binding to PrP
C at 4uC, warmed for 30 min at 37uC and processed for immunofluorescence. Rho-GDI was revealed by an anti-
His6-tag Ab. Bar: 10 mm. Note that PrP
C internalization is affected by overexpression of dominant negative isoforms of Cdc-42, Dyn 2 and Eps15 but
not by the wild-type forms.
doi:10.1371/journal.pone.0005829.g002
Table 1. Internalization of PrP
C is dependent on Cdc-42, Rho, Dyn 2, Eps15 and clathrin.
% of internalization Cdc42 wt Cdc42 N17 RhoGDI CHC siRNA
Tfr 9860.2 9361.2 9662.3 961.9
PrP
C 9662.2 5262.0 1961.4 2261.3
CTxB 9961.0 1061.5 --
% of internalization Dyn 2 wt Dyn 2 K44A Eps15 wt Eps15 D95/295
Tfr 9561.5 2561.4 9961.0 1562.5
PrP
C 9861.5 3062.6 9063.2 3462.8
Cells transfected with the different GFP-tagged wt or dominant negative isoforms, with His6-tagged Rho-GDI or siRNA against clathrin heavy chain, were analyzed by
confocal microscopy and the results were quantified with Image J software by selecting different optical sections (z stacks, see Materials and Methods) in which we
measured the intensity of fluorescence (IF)/unit of area. Data are from experiments repeated three times using 4–5 coverslips for each transfection. The amount of
internalized Tfr, PrP
C and CTxB (in 30 min of internalization) in the cells transfected with the wild-type or dominant negative GFP-tagged isoforms was expressed as a
percentage of the amount in untrasfected cells, which we set as 100% (6S.D. are indicated). The percentages of internalized PrP
C and Tfr in siRNA cells for CHC were
calculated by measuring the ratio between the average of the values of IF/unit of area in siRNA treated cells (see asterisks in the Figure 3A) and the average values of IF/




PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5829cipitates with CHC in DRMs is likely to derive from the plasma
membrane and internalized fraction. Thus, these data suggest that
a cooperative pathway exists between rafts and clathrin for PrP
C
internalization.
On the contrary the amount of PrP
C that co-immunoprecip-
itates with clathrin in non-DRMs is possibly associated with
intracellular membranes, likely with the Golgi apparatus where the
majority of PrP
C resides in FRT cells [47].
Figure 3. Endocytosis of PrP
C is both clathrin and raft-dependent. A) FRT-PrP
C cells transfected with siRNA against clathrin heavy chain
(CHCsiRNA, asterisks indicate transfected cells), were incubated with Pri308 antibody to PrP
C at 4uC, warmed for 30 min at 37uC and processed for
immunofluorescence. Clathrin was revealed with a monoclonal aclathrin antibody clone 622 (ABR bioreagents) and a TRITC-conjugated secondary
antibody; PrP
C was revealed by cy3-secondary antibody and Tfr was cy3-conjugated. The amount of clathrin and internalized PrP
C in each cell was
analyzed by Image J software from three independent experiments using 4–5 coverslips for each CHCsiRNA independent transfection. Bar: 10 mm. B)
FRT-PrP
C cells, grown in control and cholesterol depletion conditions on transwell filters were subjected to cell surface biotinylation with NH-SS-biotin
at 4uC on the basolateral side of the filters. The cells were then warmed at 37uC to allow PrP
C internalization for indicated times in medium containing
or not high sucrose. Glutathione was used to reduce the residual proteins not internalized from the plasma membrane. PrP
C was immunoprecipitated
with Pri308 or SAF32 antibody and the surface and the internalized PrP
C were revealed by western blotting with streptavidin-HRP. Data were




PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5829Discussion
Understanding the molecular mechanism that controls PrP
C
endocytic pathway is of particular interest because there is
evidence that the initial steps in the PrP
C-PrP
Sc conversion might
take place on the cell surface or during/after internalization of
PrP
C [2,5].
Current evidences in the literature indicate that PrP
C
internalization can occur via a clathrin-, caveolae-, and raft
dependent pathways [38–44].
The discrepancies between these data could be due to
differences between mammalian and chicken PrP
C sequences
(,30% homology) alternatively used in the different studies and/
or to the overexpression of exogenous PrP
C molecules in
neuroblastoma cells. Alternatively they could derive from the
different cells and the various internalization assay utilized [38–
43]. Furthermore it is not clear whether PrP
C can undertake
multiple internalization pathways in the same cell, and the
molecular factors controlling its endocytosis have not been
uncovered. This could be very relevant for both understanding
the prion pathogenesis, as stated above, but also to reveal the basis
of the different prion strains ability to infect and replicate in
different cells [71].
In order to characterize the molecular factors involved in PrP
C
endocytosis and to discriminate among clathrin, caveolae- and
raft- dependent mechanisms in PrP
C internalization we have used
the FRT cells as model system. These cells have been well
characterized for GPI-protein and PrP
C exocytosis [47,72] and do
not possess caveolae, but form de novo caveolae upon cav-1
transfection [45]. We show here that PrP
C is localized both in
coated and in smooth areas of the plasma membrane (Figure 4)
and in line with other evidence [73], it is internalized in late
endosomal/lysosomal structures (Figure 4 d–e) with a peak of
internalization after ,30 minutes (Figure 1). Based on the
circumstantial evidence of its association with caveolae or CLDs
[12,43] it was proposed earlier that PrP
C was internalized via a
caveolar pathway. By using FRT cells stably transfected with cav-1
we were able to demonstrate that this is not the case in this cell
line. Indeed while PrP
C co-localizes with cav-1 in caveoale on the
surface of FRT-PrP
C/cav-1 cells (Figure S1) it does not colocalize
with cav-1 during endocytosis. Furthermore cav-1 expression does
not have any effect on the kinetics of PrP
C internalization, which




Having excluded a role for caveolae in PrP
C endocytosis we
analyzed the role of rafts by assaying the dependence of PrP
C
internalization on cholesterol.
Interestingly we observed that following cholesterol depletion
the internalization of PrP
C was delayed, but not completely
inhibited. While these results suggest a role for rafts in PrP
C
internalization they could be explained by two possibilities. Either
the molecular mechanism involved in the PrP
C endocytic pathway
is not solely dependent on membrane rafts, or under partial
cholesterol depletion conditions the raft-dependent endocytic
pathway still functions, albeit less efficiently.
In order to discriminate between these two possibilities and to
characterize the molecular factors involved in PrP
C internaliza-
tion, we used dominant negative forms of different molecules
previously shown to be involved in clathrin- and/or raft-
dependent endocytosis [29,64,74–76].
By using the Cdc-42 N17 dominant negative form we found
that the internalization of PrP
C and CTxB, but not Tfr uptake,
were impaired (Figure 2, Table 1, Figure S3 and S4). Combined
with the effect of Rho-GDI overexpression which affects PrP
C but
Figure 4. PrP
C internalization by electron microscopy analysis. (a–c): Immunogold labeling of PrP
C on ultrathin cryosections of FRT cells
under steady-state culture conditions reveals that PrP
C (15 nm gold) is localized within both smooth and morphologically identified clathrin-coated
pits; (d–e) FRT cells have been incubated 30 min on ice in the presence of antibody against PrP. After 30 min incubation at 37uC the cells were fixed
and processed for cryo ultramicrotomy. Ultrathin cryosections were immunogold labeled using protein A-gold (15 nm). As shown also in the absence
of a possible surface cross-linking of the two antibodies due to the protein A, PrP
C reaches the endosomal compartments. Bar: a=235 nm;
b=245 nm; c=215 nm; d,e=263 nm. Arrows point to the different intracellular compartments labelled with aPrP antibodies. Morphometric analysis
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data strongly suggest that PrP
C is internalized by a raft-dependent
mechanism. However, because PrP
C endocytosis was also affected
by dominant negative Dyn K44A we could not discriminate
whether the raft-dependent pathway of PrP
C internalization was
Dynamin-dependent or whether a clathrin-mediated pathway was
also involved. Indeed, Dyn 2 regulates fission of clathrin-coated
invaginations and caveolae, but also the formation of uncoated,
raft-dependent vesicles in cells that do not express caveolae as in
the case of IL2R (Interleukin-2 Receptor) internalization [65]. In
order to distinguish between these two hypothesises we utilized the
dominant negative form of Eps15 (Eps15 D95/295) which has
Figure 5. Internalization of PrP
C occurs in DRMs. A) FRT-PrP
C cells grown for 4 days on filters and incubated with disulfide-linked biotin at 4uC,
were either solubilized immediately (surface) or first incubated for 15, 30 and 60 min at 37uC to allow internalization and then subjected to biotin
stripping by a reductive cleavage and then solubilized (internal). The cell lysates were subjected to a ‘‘Two Step’’ OptiPrep
TM density gradient to
separate DRM (fractions 4–5) from non-DRM fractions (6–12). Fraction 5 and 11 were immunoprecipitated with aPrP SAF32 antibody and biotinylated
PrP
C was revealed with streptavidin-HRP. To test the efficiency of fractionation, before PrP
C immunoprecipitation, an aliquot of fraction 5 and 11 was
immunoblotted for Flotillin-2 (Flot-2 as raft marker, [82]) and Bip/Grp78 (as non-raft marker, [80]). B) GT-1 and N2a cells grown for 4 days on dishes
were incubated with disulfide-linked biotin at 4uC and were either solubilized immediately (surface) or first incubated for 30 and 60 min at 37uCt o
allow internalization. They were then subjected to biotin stripping by a reductive cleavage and solubilized (internal). The cells were subjected to a
‘‘Two Step’’ OptiPrep
TM density gradient to separate DRM (fractions 4–5) from non-DRM fractions (6–12). Fraction 5 (DRMs) and 11 (non- DRMs) were
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[74]. Interestingly, we found that over-expression of this mutant
affected to a similar extent the internalization of PrP
C and Tfr
(Figure 2 and Figure S3), suggesting that a clathrin-dependent
pathway was also participating in PrP
C endocytosis. This was
further confirmed by the transfection of siRNA for clathrin which
affected PrP
C internalization (Figure 3A and Table 1).
The fact that PrP
C internalization is dependent on both DRMs
and clathrin was also supported by the finding that PrP
C
endocytosis was completely blocked only when the cells where
concomitantly depleted of cholesterol and incubated in a
hypertonic milieu. In order to understand whether these two
pathways were concomitant or independent from each other we
analyzed DRM association during internalization. Noteworthy,
our results show that PrP
C is in DRMs at the cell surface and
remains associated with these domains after 60 minutes of
internalization (Figure 5A) when the majority of the protein has
been endocytosed (Figure 1A, C, D, E, F) thus indicating that
clathrin assembly occurs within these domains. Furthermore, we
show that PrP
C remains associated to DRMs through all
endocytosis also in GT-1 cells (Figure 5B), thus excluding the
hypothesis that this was an idiosyncrasy of FRT cells. These data
are in agreement with the finding of Ledesma and colleagues who
described a raft-mediated mechanism for PrP
C internalization in
primary neurons [42]. In contrast Sunyach et al., reported that in
N2a cells PrP
C leaves lipid rafts to enter non-rafts membrane from
which it is internalized by a classical clathrin-mediated pathway
[40]. Importantly we were able to confirm these results in N2a
Figure 6. PrP
C and clathrin co-immunoprecipitate both in DRM and non-DRM fractions. A) FRT-PrP
C cells grown on filters were lysed,
immunoprecipitated (IP) by aPrP antibody (SAF32) or ap75
NTR antibody (as negative control), and revealed using: aCHC (TD.1) or aPrP and ap75
NTR
antibody as indicated. The supernatants (SN) of the immunoprecipitates were tested by western blot to verify the efficiency of the
coimmunoprecipitation. B) Filter grown FRT-PrP
C cells were lysed and run on OptiPrep
TM gradient to separate DRM from non-DRM fractions. The
relative distribution of CHC and PrP
C in the fractions (upper panel) was tested by western blot of an aliquot of gradient fractions with specific
antibodies. The remaining amount of each fraction (bottom panel) was immunoprecipitated with aPrP antibody SAF32 and revealed by aCHC TD.1
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between N2a, FRT and GT-1 cells were not due to the use of
different techniques but likely to cell specific differences.
Therefore, taken together our results support the hypothesis that
PrP
C can be internalized by different mechanisms in different cell
types. In addition to this concept our data indicate that PrP
C can
be internalized by different pathways in the same cell. Indeed, we
clearly show that in FRT cells both raft and clathrin are
contributing to the efficiency of PrP
C uptake. Our data also
support the possibility that rafts promote recruitment of PrP
C to
clathrin domains in a similar fashion to that demonstrated by
Abrami et al., [77] and Puri et al., [34]. Indeed it is noteworthy
that association with clathrin pits is not mutually exclusive with
association to cholesterol containing domains [77]. Earlier studies
showing low cholesterol in clathrin vesicles were due to steric
hindrance by the clathrin lattice, preventing access of filipin to the
vesicles [76]. The cooperation between rafts and clathrin in the
internalization of PrP
C could also be linked to the signalling
function proposed for PrP
C [75] which should occur in raft
domains [11] and is consistent with the hypothesis proposed for
other signalling receptors that lipid rafts could spatially coordinate
the signalling machinery while clathrin regulates their internali-
zation [30,34,35,77]. While these data support the role for rafts in
the clathrin dependent endocytosis of PrP
C our findings also point
towards a role for a clathrin-independent, raft- dependent pathway
(Figure 7). Furthermore, the fact that depletion of one of these two
components (either cholesterol for the raft-mediated pathway or
clathrin) is not sufficient to block PrP
C internalization, indicates
that PrP
C is able to enter multiple pathways in order to be
endocytosed (Figure 7). The discovery of redundant endocytic
pathway for PrP
C in the same cell line is particularly relevant if
one considers that the internalization route/s undertaken by PrP
C
can be crucial for the ability of different strains to infect, replicate
and induce cell death in different cells. Moreover, the entry in
distinct endocytic pathway in response to different stimuli could
allow PrP
C to exert both the still debated neuroprotective and
neurodegenerative functions proposed for this protein.
Further experiments are required to clarify which is the relative
contribution of raft-dependent and raft-mediated clathrin-depen-
dent pathway in PrP
C internalization.
Figure 7. Mechanisms of PrP
C internalization in FRT cells. Internalization of molecules can occur throughout many different pathways: the
classical, clathrin-mediated pathway (1); the clathrin-independent raft-dependent pathway (2); the raft-mediated clathrin-dependent route (3) and
caveolae (4). At the cell surface of FRT cells PrPC is localized in DRMs. As PrPC remains in these domains during its internalization a classical clathrin-
dependent pathway (1) seems to be excluded. Conversely PrPC can undertake a rafts dependent pathway (2) and/or rafts might promote its
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respective roles are in prion infection and conversion should now
be evaluated in infected cells.
Materials and Methods
Reagents and antibodies
Cell culture reagents were purchased from Gibco Laboratories
(Grand Island, NY). The SAF32 and Pri308 antibodies were from
Cayman Chemical (USA). Protein-A-Sepharose was from Phar-
macia Diagnostics AB (Uppsala, Sweden). The antibody against
cav-1 and His6-tag were from Santa Cruz (INC.). Polyclonal
aVAMP3 antibody was from Synaptic Systems, Germany.
Cholera toxin b subunit (CTxB) Alexa-555-conjugated was from
Molecular probes (code: C-34776). Mouse monoclonal antibodies
(mAbs) specific for CHC were 622 from ABR Bioreagents and
TD.1 [78]. Cy3- and Alexa-488-conjugated (Tfr) Transferrin were
from Invitrogen (Molecular Probes). Monoclonal ap75
NTR Ab was
a kind gift of Dr. Andre ` Le Bivic. Policlonal aBip/Grp78 antibody
was from Stressgen Biotech. aFlotillin-2 antibody was from BD
Trasduction Laboratories. Methyl-b-cyclodextrin (MbCD), mevi-
nolin and all other reagents were obtained from Sigma Chemical
Co. (St Louis, MO).
Constructs and transfections
FRT cells were stably transfected with a cDNA encoding 3F4
tagged moPrP
C with the calcium phosphate procedure, as
previously described [53].
The GFP-tagged Cdc-42 wild type or mutant (Cdc-42 N17)
were a gift from Mayor S. (National Center for Biological
Sciences, UAS-GKVK Campus, India). The GFP-tagged Eps15
wild type or dominant negative mutants (EpsD95/295) were
described previously [74] and were a gift from A. Dautry-Varsat
(Institut Pasteur, Unite ´ de Biologie des Interactions Cellulaires,
France). The GFP-tagged Dyn 2 wild type or mutant (K44A) were
gifts from MA. McNiven (Mayo Clinic, Rochester, MN; [64]).
Rho-GDI was a kind gift from Lamaze C. (Laboratoire "Trafic et
Signalisation", CNRS, Institut Curie, Paris, France).
For transient transfection FRT cells were trypsinized and
washed three times with serum free RPMI. The cells (1610
6) were
transfected by electroporation with 15 mg of plasmid encoding the
various mutants in a Biorad apparatus (300 V and 500 mF). The
cells were resuspended in F12 medium 5% FBS, plated on
coverslips and cultured for three days before endocytosis assay.
Clathrin knockdown by small interfering (siRNA)
The siRNA sequence targeting human clathrin heavy chain (59-
TAA-TCC-AAT-TCG-AAG-ACC- AAT-39) was a kind gift of
Dr. Alice Dautry-Varsat [67]. FRT cells were transfected with
100 pmol of clathrin siRNA following the procedure described
above. After three days of culture the cells were washed and used
for internalization assay. Clathrin was detected using the antibody
clone 622 from ABR Bioreagents.
Cell culture, drug treatment and cholesterol
determination
FRT cells stably expressing moPrP
C were cultured and depleted
of cholesterol as previously described [46]. Briefly, FRT cells were
plated on dishes or filters and mevinolin (10 mMo r3 0mM for
48 h) was added to the cells 24 h after plating in F12
supplemented with 5% delipidated calf serum and mevalonate
(200 mM). FRT cells were allowed to grow for another 48 h.
MbCD (10 mM) was added to the medium containing 20 mM
Hepes, pH 7.5, and 0.2% bovine albumin for 1 h at 37uC to cells
pretreated with mevinolin/mevalonate for 47 h.
GT-1 and N2a cells were grown in DMEM (Dulbecco’s
modified eagle medium) supplemented with 10% FBS.
Cholesterol determination. In order to assay cholesterol levels in
the cells before and after treatment with mevinolin/mevalonate
and methyl-b-cyclodextrin we used a colorimetric assay. FRT cells
grown in the presence or absence of mevinolin/mevalonate were
washed twice with PBS, lysed with appropriate lysis buffer and
Infinity Cholesterol Reagent (Sigma Chemical Co. ST Louis, Mo,
code number 401–25 P) was added to the lysates in the ratio 1:10
for 5 minutes at 37uC (according to the suggested Sigma protocol
number 401). The samples were then measured in a spectropho-
tometer at 550 nm.
Internalization assay: fluorescence microscopy and
biochemical analysis
Fluorescence Microscopy. Control or cholesterol depleted FRT
cells stably expressing PrP
C (or PrP
C and cav-1), were grown for 4–
5 d on filters, washed with PBS, and processed for the endocytic
assay. Briefly, the cells were incubated with anti-prion SAF32
(IgG2) antibody (2 mg/ml) 30 min at 4uC (pulse). After Ab
binding, the cells were warmed at 37uC to allow PrP
C
internalization for different indicated times (chase), the monolayers
were fixed with paraformaldehyde (PFA) and incubated with the
anti-mouse FITC-conjugated secondary antibody to label surface
PrP
C. Before permeabilization with 0.075% saponin we quenched
the free binding sites of the FITC-conjugated secondary antibody
with a rabbit a-mouse Ab. Internal PrP
C was revealed by TRITC-
conjugated secondary Ab after permeabilization.
In the case of total cav-1 detection, we used acav-1 polyclonal
primary antibody revealed by a cy5-conjugated secondary
antibody after permeabilization. Before cell permeabilization the
free binding sites of the rabbit anti-mouse Ab used for quenching
the mouse IgG of SAF32 Ab, were saturated by an anti-rabbit Ab.
The percentages of internalization were calculated, using Image
J software, by measuring the Intensity of Fluorescence (IF) per unit
of area. The fluorescent signal corresponding to the internalized
molecules was calculated considering the IF values from the whole
z stack excluding the slices corresponding to surface staining. To
avoid possible artefacts due to a wide range of expression levels of
GFP-dominant negative isoforms in transiently transfected cells,
the highest and lowest expressing cells were excluded from the
analysis. Colocalization between PrP
C and cav-1 was determined
in at least 25 cells from four different experiments under control or
cholesterol depletion conditions. The analysis was performed by
Image J or LSM 510 software and the number of colocalizing
pixels was normalized for the total number of internalized PrP
C
pixels.
Biochemical analysis. Control or cholesterol depleted FRT-
PrP
C and FRT PrP
C/cav-1 cells were grown for 4–5 d on filters,
washed with PBS, and processed for internalization assay. The
cells cooled on ice and biotinylated with NH-SS-Biotin at 4uC [79]
on the basolateral side of the filters, were held at 37uC for
indicated times. Then residual surface NH-SS biotin was removed
by reductive cleavage at 4uC with gluthatione (GSH G4251-1G,
from SIGMA). Biotinylated PrP
C was immunoprecipitated with
SAF32 antibody and revealed by western blotting using strepta-
vidin-HRP conjugated and ECL.
Block of clathrin-dependent internalization was achieved by
hypertonic treatment (120 mM NaCl, 12 mM MgSO4,1m M
EDTA, 15 mM sodium acetate, 1% w/v BSA, 100 mM HEPES
pH 7.0, 5 mM KCl and 0.4 M sucrose) 30 min before the
biochemical assay and during the chase times.
Endocytosis of PrP
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Cells grown on filters were incubated with disulfide-linked biotin
at 4uC and either solubilized immediately (surface) or first
incubated for different times at 37uC to allow internalization.
They were then subjected to biotin stripping by a reductive
cleavage and then solubilized (internal) in TNE/TX-100 1%
buffer (25 mM Tris-HCl [pH 7,5], 150 mM NaCl, 5 mM EDTA,
1%TX-100) on ice. Lysates were scraped from filters, brought to
40% OptiPREP
TM, and then placed at the bottom of a centrifuge
tube. A OptiPrep
TM gradient (5–35% TNE, [80,81]) was layered
on top of the lysates. After ultracentrifugation at 20.000 rpm for
4 h at 4uC, one ml fractions (12 fractions in total) were harvested
from the top of the gradient. Specifically, starting from the top of
the gradient the fraction 5 (representing DRMs) and 11 (non-
DRMs) were separately collected, immunoprecipitated with aPrP
and revealed with streptavidin-HRP.
Immunoprecipitation
Immunoprecipitation of PrP
C was carried out as previously
described [47].
Immunogold labeling on cryosections and morphometry
FRT-PrP
C and FRT-PrP
C/cav-1 cells were fixed in parafor-
maldehyde 2%/glutaraldehyde 0.2% in PBS, 2 h at room
temperature, scraped off the culture dish, placed in a solution of
12% gelatine in PBS. Small 1 mm
3 gelatin blocks were embedded
with 2.3 M sucrose, overnight, mounted on alluminium pins and
frozen in liquid nitrogen. Ultrathin cryosections were immunola-
belled with aPrP antibody SAF32 followed by protein A-gold
(15 nm, UMC- Utrecht) and or rabbit antibodies against cav-1
(Santacruz) and protein A-gold 10 nm, followed by aPrP and
protein A-gold (15 nm).
Alternatively the cells were incubated with aPrP SAF32 for
30 min on ice and then 20 min at 37uC prior fixation. Epon and
cryo sections were observed to Philips EM10 or Fei TECNAI
12G2 electron microscopes.
The morphometry analysis on the surface distribution of gold
particles was performed counting 1800 and 1917 gold particles
over 3612 mm of plasma membrane profiles, in FRT-PrP
C and
PrP
C/cav-1, respectively. Among these particles we identified
those associate to bona fide morphologically identified clathrin-
coated pits and caveolae stemming from the cell surface. Only
single flask-shaped caveolae clearly associated to the cell surface
were counted. We did take into consideration the gold particles
associated to organelles identifiable as caveosomes, or clusters of
flask-shaped membrane bound structures present underneath the
plasma membrane, as we could not define their potential
association to the plasma membrane. In the case of FRT-PrP
C
cells, no caveolae were identified. Data were obtained by
comparing two independent experiments.
Supporting Information
Figure S1 PrP
C localizes in caveolae in cav1-transfected FRT
cells. A) Double immunolocalization on ultrathin cryosections of
PrP
C (10 nm gold), and caveolin-1 (15 nm gold), on caveolae
stemming from the cell surface (a). Ultrathin sections of FRT-
PrP
C/cav-1 cells, incubated 30 minutes on ice in the presence of a
PrP antibody (SAF 32), followed by proteinA-gold (10 nm gold) at
37uC for 20 min, show PrP
C localized in morphological identified
caveolae at the plasma membrane (b,c). A morphometry analysis
of the distribution of gold particles identifying PrP
C shows the
presence of labeling in flask-shaped structures in the FRT-PrP
C/
cav-1 but not in the FRT-PrP
C cells. On the contrary, clathrin-
coated pits were found labeled in both type of cells. Arrowheads
indicate a PrP gold labelling (10 nm). Bar: a=238 nm;
b=360 nm; c=240 nm. Morphometric analysis on 1917 total
PrP
C gold particles revealed n=7 in caveolar structures and n=27
in CCP (clathrin-coated pits, not shown). The remaining 1883
gold particles were distributed on smooth areas of the plasma
membrane. PrP
C gold particles were counted over 3612 mmo f
plasma membrane profiles where the number of caveolae and
coated pits was comparable (not shown). Note that the percentage
of PrP
C localized in CCP is similar to wild-type FRT cells (see
Figure 4) suggesting that the transfection of caveolin-1 does not
affect the surface distribution of PrP
C. B) Lysates from FRT-PrP
C
and FRT-PrP
C/cav-1 cells were immunoblotted with a PrP
antibody SAF32. M: mature diglycosylated form, I: immature
form and U: unglycosylated form. C) Immunofluorescence of PrP
C
and cav-1 at steady-state shows a similar distribution on the cell
surface of FRT-PrP
C/cav-1 cells but not after 30 or 60 min of
internalization D), suggesting that PrP
C endocytosis is not
occurring by a caveolae-mediated mechanism (see Methods for
experimental procedure).
Found at: doi:10.1371/journal.pone.0005829.s001 (8.98 MB TIF)
Figure S2 Internalization of Tfr after cholesterol depletion. A)
FRT-PrP
C cells were grown on coverslipis and incubated for 30 at
37uC in F12 medium with Tfr Alexa 488-conjugated under
control or cholesterol depletion conditions. The cells were then
fixed with PFA and incubated with aVAMP3 antibody (a marker
of the recycling endosomes [83], after permeabilization with
saponin. Single and double immunofluorescences (merge) are
shown. As shown in panel A, we found that both in control and
cholesterol depleted cells Tfr is internalized and partially
colocalizes with VAMP3. We measured the internal intensity of
fluorescence (IF)/unit of area in optical sections (Z stacks)
comprised between the apical and basal surfaces by LSM 510
confocal microscope. A medial optical section is shown. Bar:
10 mm. B) The amount of internalized Tfr in cholesterol depleted
cells was expressed as a percentage of the amount of internalized
Tfr in control cells, which we set as 100%. Error bars are
indicated. The % of internalized Tfr was determined in at least 25
cells from four different experiments under control or cholesterol
depletion conditions. The analysis was performed by Image J
software.
Found at: doi:10.1371/journal.pone.0005829.s002 (13.57 MB
TIF)
Figure S3 Internalization of CTxB and Tfr upon transient
transfection of Cdc- 42, Dyn 2, Eps15 GFP-tagged wt or
dominant-negative mutants and of Rho-GDI (His6-tagged form).
FRT-PrP
C cells were transiently transfected with wild-type (wt) or
dominant negative mutant isoforms of GFP-tagged Eps15 (Eps
D95/295), Cdc-42 (Cdc-42 N17) or Dyn 2 (Dyn 2 K44A). His6-
tagged form of Rho-GDI was transiently transfected in FRT-PrP
C
cells that were processed for immunofluorescence as in Figure 2.
CTxB was Alexa-555 conjugated and Tfr was cy3-conjugated.
Bar: 10 mm. Data were quantified as described in Table 1.
Found at: doi:10.1371/journal.pone.0005829.s003 (4.30 MB TIF)
Figure S4 Internalization of Tfr after transient transfection of
Cdc-42 wt or N17 mutant. Internalization of Tfr was evaluated
after transient transfection of Cdc-42 wt or N17 GFP-tagged
isoforms by incubating the cells with cy3-conjugated Tfr
internalized for 30 min at 37uC. Bar: 10 mm. Data were quantified
as described in Table1.
Found at: doi:10.1371/journal.pone.0005829.s004 (5.07 MB TIF)
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transepithelial resistance after cholesterol depletion and hypertonic
treatment. A) FRT-PrP
C cells were grown on transwell permeable
filter supports (Costar), in control or cholesterol depleted
conditions and incubated for 30 min at 37uC in control or high
sucrose medium. Cells where then stained for the basolateral
marker Ag35/40 adding a specific antibody either to the apical or
basolateral side of the filters. Samples were analyzed with a Zeiss
Laser Scanning Confocal Microscope (LSM 510) equipped with a
planapo 636oil-immersion (NA 1.4) objective lens. Bar: 10 mm.
B) Transepithelial resistance (TER) was measured for 7 days after
plating 2610
6 cells on 24 mm diameter transwell filters in control
or cholesterol depletion conditions. After 4 days of culture, only
cholesterol depleted cells were incubated for 30 min at 37uCi n
high sucrose medium and TER was measured by the Millicellers
apparatus (Millipore). Note that we process the cells at 4 days of
culture, when the TER is maximal and that the combined
treatment does not affect the monolayer integrity at this time.
Found at: doi:10.1371/journal.pone.0005829.s005 (15.09 MB
TIF)
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